Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate-specific antigen: data from the European Randomized Study of Prostate Cancer Screening in Gothenburg, Sweden.
BACKGROUND: Risk models to predict prostate cancer on biopsy, whether they include only prostate-specific antigen (PSA) or other markers, are intended for use in all men of screening age. However, the association between PSA and cancer probably depends on a man's recent screening history. METHO...
Auteurs principaux: | Vickers, A, Cronin, A, Aus, G, Pihl, C, Becker, C, Pettersson, K, Scardino, P, Hugosson, J, Lilja, H |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
2010
|
Documents similaires
-
A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Goteborg, Sweden.
par: Vickers, A, et autres
Publié: (2008) -
A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden
par: Scardino Peter T, et autres
Publié: (2008-07-01) -
Follow-up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screening.
par: Zackrisson, B, et autres
Publié: (2003) -
Population-based screening for prostate cancer by measuring free and total serum prostate-specific antigen in Sweden.
par: Hugosson, J, et autres
Publié: (2003) -
Prostate specific antigen velocity does not aid prostate cancer detection in men with prior negative biopsy.
par: Vickers, A, et autres
Publié: (2010)